🇺🇸 FDA
Patent

US 11021449

Substituted triazoles and methods relating thereto

granted A61PA61P25/00A61P25/08

Quick answer

US patent 11021449 (Substituted triazoles and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P25/00, A61P25/08, A61P25/14, A61P39/02